{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:24Z","timestamp":1792460904085,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cardfail.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T09:17:53Z","timestamp":1663406273000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review"],"prefix":"10.1016","volume":"29","author":[{"given":"SYED","family":"BUKHARI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SYED ZAMRAK","family":"KHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZUBAIR","family":"BASHIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.08.008_bib0001","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","article-title":"Cardiac amyloidosis: pathology, nomenclature, and typing","volume":"24","author":"Maleszewski","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0003","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0004","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0005","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0006","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0008","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2006.01.042","article-title":"Transthyretin V122I in African Americans with congestive heart failure","volume":"47","author":"Buxbaum","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0009","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2967\/jnumed.120.245381","article-title":"Molecular imaging of cardiac amyloidosis","volume":"61","author":"Masri","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0011","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0012","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0013","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Toulouse Amyloidosis Research Network Collaborators. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality","volume":"26","author":"Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0016","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ehf2.12308","article-title":"Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience","volume":"5","author":"Mints","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0017","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of atrial fibrillation and thromboembolic risk in wild-type transthyretin amyloid cardiomyopathy","volume":"143","author":"Bukhari","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation. A systematic review","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0019","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","article-title":"Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis","volume":"68","author":"Kristen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0021","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ehf2.13851","article-title":"Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis","volume":"9","author":"Papathanasiou","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12350-021-02707-6","article-title":"Interatrial septal 99mTc-pyrophosphate uptake and reduced strain in wild-type transthyretin amyloid cardiomyopathy","volume":"29","author":"Aikawa","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.84.1.40","article-title":"Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients","volume":"84","author":"Middlekauff","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0024","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0025","first-page":"VI102","article-title":"The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group","volume":"87","author":"Carson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0026","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ehj.2004.04.007","article-title":"Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation","volume":"25","author":"Leone","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0027","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.0000034511.06350.DF","article-title":"Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"R\u00f6cken","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0028","first-page":"71","article-title":"Cardiac amyloidosis and its new clinical phenotype: heart failure with preserved ejection fraction","volume":"109","author":"Mesquita","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0029","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9149(81)90175-2","article-title":"Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis","volume":"47","author":"Tyberg","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0030","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199211263272205","article-title":"Brief report: atrial systolic failure in primary amyloidosis","volume":"327","author":"Plehn","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0031","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0032","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jeaa043","article-title":"Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology","volume":"22","author":"Brand","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0033","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaccao.2020.10.010","article-title":"Left atrial mechanics associates with paroxysmal atrial fibrillation in light-chain amyloidosis following stem cell transplantation","volume":"2","author":"Lohrmann","year":"2020","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0034","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.53.2.273","article-title":"Relation between echocardiographically determined left atrial size and atrial fibrillation","volume":"53","author":"Henry","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cvr\/cvq357","article-title":"Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation","volume":"89","author":"De Jong","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0036","doi-asserted-by":"crossref","first-page":"e72651","DOI":"10.1371\/journal.pone.0072651","article-title":"Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload","volume":"8","author":"De Jong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0037","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0038","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ejhf.2566","article-title":"Systemic embolism in amyloid transthyretin cardiomyopathy","volume":"24","author":"Vilches","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0039","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2021.04.042","article-title":"Atrial fibrillation and ischemic stroke with the amyloidogenic V122I transthyretin variant among Black Americans","volume":"78","author":"Selvaraj","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13506129.2020.1798922","article-title":"Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation","volume":"28","author":"Cappelli","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0042","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0043","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2019.01.035","article-title":"High prevalence of intracardiac thrombi in cardiac amyloidosis","volume":"73","author":"Martinez-Naharro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0044","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13506129.2020.1810010","article-title":"Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding","volume":"28","author":"Mitrani","year":"2021","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis","volume":"73","author":"El-Am","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0046","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/03009740510015203","article-title":"AL cardiac amyloidosis and arterial thromboembolic events","volume":"34","author":"Hausfater","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0047","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.jacc.2019.02.078","article-title":"Predicting the unpredictable: how to score the risk of stroke in cardiac amyloidosis?","volume":"73","author":"Russo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0048","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/01.wnl.0000276951.39112.2b","article-title":"Primary systemic amyloidosis with ischemic stroke as a presenting complication","volume":"69","author":"Zubkov","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0049","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.10552","article-title":"Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis","volume":"53","author":"Berghoff","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0050","first-page":"449","article-title":"Monoclonal autoimmunity in hematology","volume":"76","author":"Marmont","year":"1991","journal-title":"Haematologica"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0051","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/13506129909007339","article-title":"Abnormalities in thrombin-antithrombin pathway in AL amyloidosis","volume":"6","author":"Gamba","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0052","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1983.03330340064034","article-title":"Bleeding manifestations in 100 patients with amyloidosis","volume":"249","author":"Yood","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2022.08.008_bib0053","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","article-title":"Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis","volume":"110","author":"Mumford","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422007072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422007072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:31Z","timestamp":1761029371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916422007072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1071916422007072"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.08.008","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}